8. Network effect estimates and ranking statistics for oliguria.

Acetaminophen Mean SUCRA, 0.86; median rank, 1 (95% CrI, 1‐4)
0.52 ( 0.14, 1.62)	Ibuprofen Mean SUCRA, 0.35; median rank, 3 (95% CrI, 1‐4)
0.40 ( 0.12, 1.23)	0.78 ( 0.46, 1.34)	Indomethacin Mean SUCRA, 0.08; median rank, 4 (95% CrI, 3‐4)
0.68 ( 0.20, 1.97)	1.32 ( 0.85, 2.02)	1.69 ( 1.20, 2.29)	Placebo Mean SUCRA, 0.71; median rank, 2 (95% CrI, 1‐3)

The unlabeled data in the boxes are risk ratios (RRs) and 95% credible intervals (CrIs). A RR >1 suggests that the upper left treatment is associated with a higher risk of having the outcome of interest vs the corresponding lower right treatment and the opposite is true for an RR <1. SUCRA, surface under the cumulative ranking curve